Minimal-Access Surgery for Staging of Malignant Melanoma

Archives of Surgery

Volumn 130, Issue 6, 1995, Pages 654-658

  Krag, David N ^a   Meijer, Sybren J ^c,d   Weaver, Donald L ^b   Loggie, Brian W ^e   Harlow, Seth P ^a   Tanabe, Kenneth K ^f   Laughlin, Edward H ^g   Alex, James C ^a  

^a Departments of Surgery   (United States)

^b Departments of Pathology   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; ISOSULFAN BLUE; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; HUMAN; INTRADERMAL DRUG ADMINISTRATION; ISOTOPE LABELING; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; HUMAN; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA; MIDDLE AGE; NEOPLASM STAGING; STAINING AND LABELING;

EID: 0029074162     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.1995.01430060092018     Document Type: Article

References (39)

1. Wingo PA, Tong T, Bolden S. Cancer statistics 1995: CA-A. Cancer J Clinician. 1995;45:1-35.
2. Johnson P, Dragstedt LR II. Malignant melanoma: a disease on the increase. Iowa Med. May 1988:221-223.
3. Balch CM, Soong S-J, Shaw HM, et al. Changing trends in the clinical pathological features of melanoma. In: Balch CM, Houghton AN, Milton GW, Sober A, Soong S-J, eds. Cutaneous Melanoma. 2nd ed. Philadelphia, Pa: JB Lippincott; 1992:40-45.
4. Balch CM, Soong S-J, Milton GW, et al. A comparison of prognostic factors and surgical results in 1786 patients with localized (stage 1) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg. 1982;196:677-684.
5. Veronesi U, Cascinelli N. Narrow excision (1-cm margin): a safe procedure for thin cutaneous melanoma. Arch Surg. 1991;126:438-441.
6. Veronesi U, Cascinelli N, Adamus J, et al. Thin stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N Engl J Med. 1988;318:1159-1162.
7. Balch CM, Urist MM, Karakousis CP, et al. Efficacy of 2-cm surgical margins for intermediate thickness melanomas (1 to 4 mm): result of multiinstitutional randomized surgical trial. Ann Surg. 1993;218:262-267.
8. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;230:759-767.
9. Singletary SE, Shallenberger R, Guinee VF, McBride CM. Melanoma with metastasis to regional axillary or inguinal lymph nodes: prognostic factors and results of surgical treatment in 714 patients. South Med J. 1988;81:5-9.
10. Calabro A, Singletary SE, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg. 1989;124:1051-1055.
11. Sim FH, Taylor WF, Prithcard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc. 1986;61:697-705.
12. Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med. 1977;297:627-630.
13. Veronesi U, Adams J, Bandiera DC, et al. Delayed regions lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer. 1982; 49:420-430.
14. Veronesi U, Adamus J, Bandiera DC, et al. Stage I melanoma of the limbs: immediate versus delayed node dissection. Tumori. 1980;66:373-396.
15. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
16. Alex JC, Krag DN. Gamma-probe—guided localization of lymph nodes. Surg Oncol. 1993;2:137-144.
17. Alex JC, Weaver DL, Fairbank JT, Rankin BS, Krag DN. Gamma-probe—guided lymph node localization in malignant melanoma. Surg Oncol. 1993;2:303-308.
18. Krag DN, Ford PV, Patel M, Schneider PO, Goodnight JR Jr. A simplified technique to resect abnormal bony radiolocalizations using a gamma counter. Surg Oncol. 1992;1:371-377.
19. Ross Ml. The case for elective lymphadenectomy. Surg Oncol Clin North Am. 1992;1:205-222.
20. Fee HJ, Robinson DS, Sample WF, et al. The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study. Surgery. 1978;84:626-632.
21. Sullivan DC, Croker BP, Harris CC, et al. Lymphoscintigraphy in malignant melanoma: 99m Tc antimony sulfur colloid. AJR Am J Roentgenol. 1981;137:847-851.
22. Meyer CM, Lecklitner Ml, Logic JR, et al. Technetium-99m sulfur-colloid cutaneous lymphoscintigraphy in the management of truncal melanoma. Radiology. 1979;131:205-209.
23. Lamki LM, Logic JR. Defining lymphatic drainage patterns with cutaneous lympohoscintigraphy. In: Balch CM, Houghton AN, Milton GW, Sober J, Soong S-J, eds. Cutaneous Melanoma. 2nd ed. Philadelphia, Pa: JB Lippincott; 1992: 367-375.
24. Slingluff CL, Stidham KR, Ricci WM, Stanley WE, Seigler HF. Surgical management of regional lymph nodes in patients with melanoma: experience with 4682 patients. Ann Surg. 1994;219:120-130.
25. Holmes EC, Moseley HS, Morton DL, Clark W, Robinson D, Urist MM. A rational approach to the surgical management of melanoma. Ann Surg. 1977; 186:481-490.
26. Balch CM, Murad TM, Soong S-J, Ingalls AL, Richards PC, Maddox WA. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer. 1979;43:883-888.
27. Das Gupta TK. Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study. Ann Surg. 1977;186:201-209.
28. Bennett LR, Lago G. Cutaneous lymphoscintigraphy in malignant melanoma. Semin Nucl Med. 1983;13:61-69.
29. Lock-Andersen J, Rossing N, Drzewiecki KT. Preoperative cutaneous lymphoscintingraphy in malignant melanoma. Cancer. 1989;63:77-82.
30. Roses DF, Harris MN, Rigel D, Carry Z, Friedman R, Kopf AW. Local and intransit metastases following definitive excision for primary cutaneous malignant melanoma. Ann Surg. 1983;198:65-69.
31. Balch CM, Soong S-J, Milton GW, et al. Ann Surg. 1982;196:677-684.
32. Balch CM, Birmingham AL. Surgical management of regional lymph nodes in cutaneous melanoma. J Am Acad Dermatol. 1980;3:511-524.
33. Krag DN. Gamma Probes for Intraoperative Detection of Radiolabeled Tissues [workshop handout]. Burlington, Vt: University of Vermont; 1993.
34. Krag DN. Gamma Probes for Intraoperative Detection of Radiolabeled Tissues [workshop handout]. Burlington, Vt: University of Vermont; 1994.
35. Haagensen CD. Diseases of the Breast. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1971:1-54.
36. Berman CG, Norma J, Cruse CW, et al. Lymphoscintigraphy in malignant melanoma. Ann Plast Surg. 1992;28:29-32.
37. Balch CM, Houghton AN, Peters LJ. Cutaneous melanoma. Devita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 4th ed. Philadelphia, Pa: JB Lippincott; 1993:1612-1661.
38. Balch CM, Soong S-J, Murad TM, et al. A multifactorial analysis of melanoma, III: prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg. 1981;193:377-388.
39. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;3:335-340.